UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$25.3B |
| 2 |
Bank of America
BAC
|
+$1.96B |
| 3 |
Applied Materials
AMAT
|
+$1.43B |
| 4 |
NetEase
NTES
|
+$1.18B |
| 5 |
Union Pacific
UNP
|
+$870M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$7.17B |
| 2 |
Apple
AAPL
|
+$3.39B |
| 3 |
UBS Group
UBS
|
+$2.73B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.53B |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.88% |
| 2 | Financials | 12.37% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Healthcare | 9.66% |
| 5 | Communication Services | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Strategic Education
STRA
$1.83B
| $3.11M | ﹤0.01% |
36,127
-33,623
| -48% | -$2.71M |
|
1577
Liberty Latin America Class C
LILAK
$1.66B
| $3.09M | ﹤0.01% |
403,088
-221,940
| -36% | -$1.52M |
|
1578
Northwest Bancshares
NWBI
$2.28B
| $3.09M | ﹤0.01% |
249,084
-172,238
| -41% | -$2.17M |
|
1579
Vertex
VERX
$1.95B
| $3.08M | ﹤0.01% |
124,180
-79,435
| -39% | -$2.3M |
|
1580
Harmonic Inc
HLIT
$1.26B
| $3.08M | ﹤0.01% |
302,303
-210,915
| -41% | -$1.99M |
|
|
DMC
1581
Del Monte Corp
DMC
$1.45B
| $3.08M | ﹤0.01% |
88,608
-84,473
| -49% | -$2.99M |
|
1582
Trupanion
TRUP
$1.33B
| $3.07M | ﹤0.01% |
70,918
-43,161
| -38% | -$2.05M |
|
1583
Enovix
ENVX
$1.02B
| $3.07M | ﹤0.01% |
307,494
-347,675
| -53% | -$3.85M |
|
1584
Interface
TILE
$2.22B
| $3.05M | ﹤0.01% |
105,552
-74,707
| -41% | -$1.88M |
|
|
SCS
1585
DELISTED
Steelcase
SCS
| $3.03M | ﹤0.01% |
176,191
-152,772
| -46% | -$2.21M |
|
|
PRA
1586
DELISTED
ProAssurance
PRA
| $3.03M | ﹤0.01% |
126,234
-79,652
| -39% | -$1.9M |
|
1587
Federal Agricultural Mortgage
AGM
$2.58B
| $3.02M | ﹤0.01% |
17,952
-16,564
| -48% | -$3.1M |
|
1588
Protolabs
PRLB
$2.17B
| $3.01M | ﹤0.01% |
60,237
-41,194
| -41% | -$1.89M |
|
1589
TripAdvisor
TRIP
$1.28B
| $3.01M | ﹤0.01% |
184,857
-153,247
| -45% | -$2.67M |
|
1590
PAR Technology
PAR
$732M
| $3M | ﹤0.01% |
75,829
-60,541
| -44% | -$3.34M |
|
1591
Viridian Therapeutics
VRDN
$2.69B
| $3M | ﹤0.01% |
138,980
-51,124
| -27% | -$922K |
|
1592
BioCryst Pharmaceuticals
BCRX
$2.69B
| $3M | ﹤0.01% |
394,740
-297,229
| -43% | -$2.48M |
|
1593
Tilray
TLRY
$629M
| $3M | ﹤0.01% |
173,165
-160,391
| -48% | -$1.53M |
|
1594
Array Technologies
ARRY
$819M
| $2.97M | ﹤0.01% |
364,127
-299,563
| -45% | -$2.27M |
|
1595
Worthington Enterprises
WOR
$2.8B
| $2.96M | ﹤0.01% |
53,416
-52,342
| -49% | -$3.3M |
|
1596
Vericel Corp
VCEL
$2.3B
| $2.95M | ﹤0.01% |
93,662
-69,288
| -43% | -$2.49M |
|
1597
Standard Motor Products
SMP
$886M
| $2.95M | ﹤0.01% |
72,193
-29,871
| -29% | -$1.09M |
|
1598
Insperity
NSP
$1.95B
| $2.94M | ﹤0.01% |
59,780
-44,280
| -43% | -$2.42M |
|
1599
Arlo Technologies
ARLO
$1.6B
| $2.94M | ﹤0.01% |
173,495
-102,327
| -37% | -$1.74M |
|
1600
Teladoc Health
TDOC
$1.25B
| $2.93M | ﹤0.01% |
379,446
-290,083
| -43% | -$2.26M |
|
Similar funds
UBS AM's Q3 2025 Portfolio in Review
As of Q3 2025, UBS AM held 2,672 positions worth $461B, down 6.8% from $494B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
UBS AM withdrew a net $68.7B in Q3 2025, closing 403 positions and reducing 2,008 holdings. Its most notable exit was Pinduoduo, an estimated $967M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Vanguard Dividend Appreciation ETF worth $135M.
- UBS AM's largest Q3 2025 buy was Vanguard Dividend Appreciation ETF: 624,303 shares worth $135M.
- UBS AM added most to Microsoft in Q3 2025, an estimated $25.3B increase.
- UBS AM's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $7.17B.
- UBS AM fully exited Pinduoduo in Q3 2025, selling an estimated $967M.
- UBS AM's ten largest holdings make up 35% of its $461B portfolio in Q3 2025.
- UBS AM opened 67 new positions and closed 403 in Q3 2025.
- UBS AM's portfolio value fell 6.8% quarter-over-quarter to $461B.
Based on UBS AM's 13F filing for Q3 2025, filed 14 Nov 2025.